Delivery Order SPE2DB24D9144-SPE2DB24FCMMK
Award Date
9/27/24
Potential Completion Date
10/21/24
Potential Value
$1.5K
Federal Agency
Defense Logistics Agency
Awardee
DMS Pharmaceutical Group Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is a firm fixed-price Delivery Order (SPE2DB23FQ60G) valued at $15,474.00 for the supply of XOLAIR 150 MG/ML syringes. The contract is awarded under the Defense Logistics Agency's (DLA) SPE2DB program, a $499,999,999 indefinite delivery contract (IDC) that runs through December 31, 2025. This IDC allows the DLA to issue delivery orders to DMS Pharmaceutical Group for a...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, was issued by the Defense Logistics Agency (DLA) as a firm fixed-price delivery order under a $499,999,999 Indefinite Delivery Contract (IDC). The contract covers the supply of a diverse range of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to support the medical needs of the Department of Defense (DoD)...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is a firm fixed-price delivery order valued at $9,284.40. The contract was awarded by the Defense Logistics Agency (DLA) and has no set-aside designation. It is part of the DLA's larger SPE2DB Indefinite Delivery Contract (IDC) valued at up to $499,999,999, which allows the agency to issue delivery orders for a comprehensive range of pharmaceutical products to support the medical supply needs of...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, was issued by the Defense Logistics Agency (DLA) for the delivery of XOLAIR 300 MG/2 ML AUTOINJECT 2ML medical supplies. The $3,424.46 firm fixed-price delivery order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program. This IDC enables the DLA to issue delivery orders for a comprehensive range of pharmaceutical...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The award, valued at $3,877.70, is for the supply of XOLAIR 75 MG/0.5 ML SYRINGE 0.5ML, a specialized pharmaceutical product. The award is part of a larger indefinite delivery contract (IDC) between DMS Pharmaceutical Group and the DLA, valued at up to $499,999,999, which runs through...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $13,926.60 firm fixed-price delivery order is for the supply of XOLAIR 75 MG/0.5 ML SYRINGE 0.5ML, with an ultimate completion date of October 28, 2024. The award is part of a larger $499,999,999 single-award indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, was issued by the Defense Logistics Agency (DLA) under the SPE2DB program. The $9,284.40 firm fixed-price delivery order is for the supply of XOLAIR 150 MG/ML SYRINGEML, a pharmaceutical product, with an ultimate completion date of October 25, 2024. This award is part of a larger $499,999,999 indefinite delivery contract (IDC) between DMS Pharmaceutical Group and the DLA, which allows the agency to...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is a firm fixed-price delivery order worth $7,737 under the Defense Logistics Agency's (DLA) SPE2DB24FL1C9 indefinite delivery contract. The contract is for the supply of the pharmaceutical product XOLAIR 75 MG/0.5 ML SYRINGE 0.5ML, with an ultimate completion date of June 7, 2024. DMS Pharmaceutical Group is a key supplier in the federal pharmaceutical supply chain, providing a wide range of...
This contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is for the delivery of XOLAIR 150 MG/ML SYRINGEML, a specialized pharmaceutical product. The $15,474.00 firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) on November 18, 2024, with a completion date of December 10, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $499,999,999 that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program....
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is a firm fixed-price delivery order (SPE2DB24FL0H6) under the Defense Logistics Agency's (DLA) SPE2DB program. The $9,284.40 award is for the supply of XOLAIR 75 MG/0.5 ML SYRINGE 0.5ML, a pharmaceutical product, to fulfill the recurring medical supply needs of military health facilities. DMS Pharmaceutical Group is an established federal contractor that provides a comprehensive range of pharmaceutical...